Kensington Capital Acquisition Corp. V (KCGI) 10-Q 14 Aug 24 2024 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2024	Aug. 14, 2024
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31
Document Quarterly Report	true
Document Transition Report	false
Entity Registrant Name	KENSINGTON CAPITAL ACQUISITION CORP. V
Entity Central Index Key	0001865407
Entity Interactive Data Current	Yes
Entity Current Reporting Status	Yes
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1592043
Entity File Number	001-40741
Entity Address, Address Line One	1400 Old Country Road
Entity Address, Address Line Two	Suite 301
Entity Address, City or Town	Westbury
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11590
City Area Code	703
Local Phone Number	674-6514
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and three-fourths of one redeemable warrant
Trading Symbol	KCGI.U
Security Exchange Name	NYSE
Class A ordinary shares [Member]
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary shares
Trading Symbol	KCGI
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		4,542,733
Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	KCGI WS
Security Exchange Name	NYSE
Class B ordinary shares [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		6,900,000

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash	$ 879,486	$ 1,222,918
Prepaid expenses	69,814	127,183
Total current assets	949,300	1,350,101
Investments held in Trust Account	50,736,202	49,216,721
Total Assets	51,685,502	50,566,822
Current liabilities:
Accounts payable	129,036	132,705
Accrued expenses	2,268,650	2,140,748
Working Capital Loan -current related party	1,100,250	1,100,250
Total current liabilities	3,497,936	3,373,703
Deferred underwriting commissions in connection with the initial public offering	9,660,000	9,660,000
Derivative warrant liabilities	1,182,600	3,942,000
Total Liabilities	14,340,536	16,975,703
Commitments and Contingencies (Note 5)
Shareholders' Deficit
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of June 30, 2024 and December 31, 2023
Additional paid-in capital	0	0
Accumulated deficit	(13,291,926)	(15,526,292)
Total shareholders' deficit	(13,291,236)	(15,525,602)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	51,685,502	50,566,822
Class A ordinary shares [Member]
Current liabilities:
Class A ordinary shares subject to possible redemption, 4,542,733 shares at redemption value of approximately $11.15 and $10.81 per share as of June 30, 2024 and December 31, 2023, respectively	50,636,202	49,116,721
Shareholders' Deficit
Common stock	0	0
Class B ordinary shares [Member]
Shareholders' Deficit
Common stock	$ 690	$ 690

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2024	Dec. 31, 2023
Preference stock, Par or stated value per share	$ 0.0001	$ 0.0001
Preference stock, Shares authorized	1,000,000	1,000,000
Preference stock, Shares issued	0	0
Preference stock, Shares outstanding	0	0
Class A ordinary shares [Member]
Temporary equity shares issued	4,542,733	4,542,733
Temporary equity shares outstanding	4,542,733	4,542,733
Temporary equity redemption value per share	$ 11.15	$ 10.81
Common stock, par or stated value per share	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	4,542,733	4,542,733
Common stock, shares outstanding	4,542,733	4,542,733
Class A ordinary shares [Member] | Not Subject To Redemption [Member]
Common stock, shares issued	0	0
Common stock, shares outstanding	0	0
Class B ordinary shares [Member]
Common stock, par or stated value per share	$ 0.0001	$ 0.0001
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	6,900,000	6,900,000
Common stock, shares outstanding	6,900,000	6,900,000

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
General and administrative expenses	$ 178,795	$ 883,661	$ 405,034	$ 1,906,326
Selling, General, and Administrative Expenses, Related Party, Type [Extensible Enumeration]	Related Party [Member]	Related Party [Member]	Related Party [Member]	Related Party [Member]
Administrative expenses - related party	$ 60,000	$ 0	$ 120,000	$ 20,000
Loss from operations	(238,795)	(883,661)	(525,034)	(1,926,326)
Other income:
Change in fair value of derivative warrant liabilities	1,182,600	6,701,400	2,759,400	3,474,200
Income from investments held in Trust Account	652,586	2,522,626	1,519,481	5,254,780
Total other income	1,835,186	9,224,026	4,278,881	8,728,980
Net income	1,596,391	8,340,365	3,753,847	6,802,654
Common Class A [Member]
Other income:
Net income	$ 633,763	$ 6,672,292	$ 1,490,267	$ 5,442,123
Weighted average shares outstanding basic	4,542,733	27,600,000	4,542,733	27,600,000
Weighted average shares outstanding diluted	4,542,733	27,600,000	4,542,733	27,600,000
Basic net income per share	$ 0.14	$ 0.24	$ 0.33	$ 0.2
Diluted net income per share	$ 0.14	$ 0.24	$ 0.33	$ 0.2
Common Class B [Member]
Other income:
Net income	$ 962,628	$ 1,668,073	$ 2,263,580	$ 1,360,531
Weighted average shares outstanding basic	6,900,000	6,900,000	6,900,000	6,900,000
Weighted average shares outstanding diluted	6,900,000	6,900,000	6,900,000	6,900,000
Basic net income per share	$ 0.14	$ 0.24	$ 0.33	$ 0.2
Diluted net income per share	$ 0.14	$ 0.24	$ 0.33	$ 0.2

Condensed Statements of Changes

Condensed Statements of Changes in Shareholders' Deficit - USD ($)	Total	Class A ordinary shares [Member]	Class B ordinary shares [Member]	Common Stock [Member] Class A ordinary shares [Member]	Common Stock [Member] Class B ordinary shares [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2022	$ (15,083,590)			$ 0	$ 690	$ 0	$ (15,084,280)
Beginning balance, shares at Dec. 31, 2022				0	6,900,000
Excess of cash received over fair value of Additional Private Placement Warrants	2,208,000					2,208,000	0
Remeasurement of redemption value of Class A ordinary shares subject to possible redemption	(5,492,154)					(2,208,000)	(3,284,154)
Net Income (Loss)	(1,537,711)						(1,537,711)
Ending balance at Mar. 31, 2023	(19,905,455)			$ 0	$ 690	0	(19,906,145)
Ending balance, shares at Mar. 31, 2023				0	6,900,000
Beginning balance at Dec. 31, 2022	(15,083,590)			$ 0	$ 690	0	(15,084,280)
Beginning balance, shares at Dec. 31, 2022				0	6,900,000
Net Income (Loss)	6,802,654	$ 5,442,123	$ 1,360,531
Ending balance at Jun. 30, 2023	(14,087,716)			$ 0	$ 690	0	(14,088,406)
Ending balance, shares at Jun. 30, 2023				0	6,900,000
Beginning balance at Dec. 31, 2022	(15,083,590)			$ 0	$ 690	0	(15,084,280)
Beginning balance, shares at Dec. 31, 2022				0	6,900,000
Remeasurement of redemption value of Class A ordinary shares subject to possible redemption		(9,377,784)
Ending balance at Dec. 31, 2023	(15,525,602)			$ 0	$ 690	0	(15,526,292)
Ending balance, shares at Dec. 31, 2023				0	6,900,000
Beginning balance at Mar. 31, 2023	(19,905,455)			$ 0	$ 690	0	(19,906,145)
Beginning balance, shares at Mar. 31, 2023				0	6,900,000
Remeasurement of redemption value of Class A ordinary shares subject to possible redemption	(2,522,626)					0	(2,522,626)
Net Income (Loss)	8,340,365	6,672,292	1,668,073				8,340,365
Ending balance at Jun. 30, 2023	(14,087,716)			$ 0	$ 690	0	(14,088,406)
Ending balance, shares at Jun. 30, 2023				0	6,900,000
Beginning balance at Dec. 31, 2023	(15,525,602)			$ 0	$ 690	0	(15,526,292)
Beginning balance, shares at Dec. 31, 2023				0	6,900,000
Remeasurement of redemption value of Class A ordinary shares subject to possible redemption	(866,895)					0	(866,895)
Net Income (Loss)	2,157,456						2,157,456
Ending balance at Mar. 31, 2024	(14,235,041)			$ 0	$ 690	0	(14,235,731)
Ending balance, shares at Mar. 31, 2024				0	6,900,000
Beginning balance at Dec. 31, 2023	(15,525,602)			$ 0	$ 690	0	(15,526,292)
Beginning balance, shares at Dec. 31, 2023				0	6,900,000
Remeasurement of redemption value of Class A ordinary shares subject to possible redemption		(1,519,481)
Net Income (Loss)	3,753,847	1,490,267	2,263,580
Ending balance at Jun. 30, 2024	(13,291,236)			$ 0	$ 690	0	(13,291,926)
Ending balance, shares at Jun. 30, 2024				0	6,900,000
Beginning balance at Mar. 31, 2024	(14,235,041)			$ 0	$ 690	0	(14,235,731)
Beginning balance, shares at Mar. 31, 2024				0	6,900,000
Remeasurement of redemption value of Class A ordinary shares subject to possible redemption	(652,586)					0	(652,586)
Net Income (Loss)	1,596,391	$ 633,763	$ 962,628				1,596,391
Ending balance at Jun. 30, 2024	$ (13,291,236)			$ 0	$ 690	$ 0	$ (13,291,926)
Ending balance, shares at Jun. 30, 2024				0	6,900,000

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Cash Flows from Operating Activities:
Net Income (Loss)	$ 1,596,391	$ 8,340,365	$ 3,753,847	$ 6,802,654
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	(1,182,600)	(6,701,400)	(2,759,400)	(3,474,200)
Income from investments held in Trust Account			(1,519,481)	(5,254,780)
Changes in operating assets and liabilities:
Prepaid expenses			57,369	80,362
Accounts payable			(3,669)	204,708
Accrued expenses			127,902	1,407,021
Net cash used in operating activities			(343,432)	(234,235)
Cash Flows from Investing Activities:
Cash deposited in Trust Account			0	(2,760,000)
Net cash used in investing activities			0	(2,760,000)
Cash Flows from Financing Activities:
Proceeds received from private placement			0	2,760,000
Net cash provided by financing activities			0	2,760,000
Net change in cash			(343,432)	(234,235)
Cash - beginning of the period			1,222,918	1,235,676
Cash - end of the period	$ 879,486	$ 1,001,441	879,486	1,001,441
Supplemental disclosure of non-cash activities:
Remeasurement of redemption value of Class A ordinary shares subject to possible redemption			$ 1,519,481	$ 5,254,780

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 1,596,391	$ 2,157,456	$ 8,340,365	$ (1,537,711)	$ 3,753,847	$ 6,802,654

Insider Trading Arrangements

Insider Trading Arrangements	6 Months Ended
	Jun. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Description of Organization and

Description of Organization and Business Operations	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization and Business Operations	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Kensington Capital Acquisition Corp. V (the “Company” or “Kensington”) was incorporated on March 19, 2021 as a Cayman Islands exempted company. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of June 30, 2024, the Company had not commenced any operations. All activity for the period from March 19, 2021 (inception) through June 30, 2024 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and since the Initial Public Offering, its search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. On August 1, 2024, the Company issued a press release announcing it will not complete a Business Combination and will redeem all of its outstanding Class A ordinary shares. The redemption is expected to occur on August 19, 2024. The Company’s sponsor is Kensington Capital Sponsor V LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on August 12, 2021. On August 17, 2021, the Company consummated its Initial Public Offering of 27,600,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), which includes the exercise in full of the underwriters’ option to purchase 3,600,000 Units, at $10.00 per Unit, generating gross proceeds of $276.0 million, and incurring offering costs of approximately $15.7 million, of which approximately $9.7 million and approximately $889,000 was for deferred underwriting commissions (see Note 5) and offering costs allocated to derivate warrant liabilities, respectively. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (the “Initial Private Placement” and together with the Additional Private Placement (as defined below), the “Private Placements”) of 11,360,000 warrants (each, a “Private Placement Warrant” and collectively with the Additional Private Placement Warrants (as defined below), the “Private Placement Warrants”) at a price of $0.75 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $8.5 million (see Note 4). Upon closing of the Initial Public Offering and the Initial Private Placement, $276.0 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and of the Private Placement Warrants in the Initial Private Placement were placed in a trust account (the “Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities,” within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 On each of August 4, 2022 and February 15, 2023, in connection with the Extensions as described below, the Company consummated an additional private placement (each, an “Additional Private Placement” and collectively, the “Additional Private Placements”) of 3,680,000 warrants (each, an “Additional Private Placement Warrant” and collectively, the “Additional Private Placement Warrants”) at a price of $0.75 per Additional Private Placement Warrant, generating total proceeds in aggregate of $5,520,000. The Additional Private Placement Warrants were purchased by the Sponsor and are substantially similar to the Private Placement Warrants issued to the Sponsor at the time of the Company’s Initial Public Offering. The Additional Private Placement Warrants were issued pursuant to, and are governed by, the Warrant Agreement that the Company entered into at the time of the Initial Public Offering. Upon closing of the Additional Private Placements, the proceeds received by the Company in connection with the issuance of the Additional Private Placement Warrants were deposited in the Trust Account. On August 11, 2023 and August 14, 2023, the Sponsor and the Company entered into agreements (the “Non-Redemption (the “Non-Redeemed Sponsor agreed to transfer to such investors an aggregate of 568,750 Class B ordinary shares of the Company held by the Sponsor immediately following the consummation of an initial business combination if they continued to hold such Non-Redeemed the Non-Redemption the Non-Redemption The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company must complete an initial Business Combination with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount). However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company’s amended and restated memorandum and articles of association (the “Memorandum and Articles”) provide that a holder of the Company’s outstanding Class A ordinary shares, par value $0.0001 per share, sold in the Initial Public Offering (“Public Shareholder”), together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and directors (the “initial shareholders”) agreed, pursuant to a letter agreement with the Company, that they will not propose any amendment to the Memorandum and Articles (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination by August 17, 2024 (the “Combination Period”) or (B) with respect to any other provision relating to shareholders’ rights or pre-initial a per-share The Company initially had 12 months from the closing of the Initial Public Offering to consummate the initial Business Combination. However, if the Company anticipated that it may not be able to consummate the initial Business Combination within 12 months, the Company was permitted to, by resolution of its board of directors at the option of the Sponsor, extend the period of time the Company had to consummate an initial Business Combination up to two times, each by an additional 6 months (for a total of up to an additional 12 months from the closing of the Initial Public Offering), subject to the Sponsor purchasing additional Private Placement Warrants. The Company’s shareholders were not entitled to vote on or redeem their shares in connection with any such extension. Pursuant to the terms of the Memorandum and Articles, in order to extend the period of time to consummate an initial Business Combination in such a manner, the Sponsor had to purchase an additional 3,680,000 Private Placement Warrants, at a price of $0.75 per warrant, and deposit $0.10 per each Unit (for an aggregate of approximately $2.8 million), in proceeds into the Trust Account on or prior to the date of the applicable deadline, for each 6-month On August 1, 2024, the Company issued a press release announcing that it will be unable to complete a business combination and intends to dissolve and liquidate in accordance with the provisions of its Memorandum and Articles. The initial shareholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares (as defined below in Note 4) held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only, or less than, $10.00. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Risks and Uncertainties The continuing military conflict between the Russian Federation and Ukraine, the military action between Hamas and Israel, and the risk of escalations of other military conflicts have created and are expected to create global economic consequences. The impact of these actions and related sanctions on the world economy are not determinable as of the date of these unaudited condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements. Liquidity and Going Concern As of June 30, 2024, the Company had approximately $0.9 million in its operating bank account and a working capital deficit of approximately $2.5 million. The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover for certain expenses on behalf of the Company in exchange for issuance of Founder Shares (as defined in Note 4), and the loan from the Sponsor of approximately $150,000 under the Note (as defined in Note 4), which was converted into a Working Capital Loan (as defined in Note 4) on August 17, 2021. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity needs have been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Initial Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). As of June 30, 2024 and December 31, 2023, the fair value of the Working Capital Loan was $150,000 (see Note 4). On August 29, 2023, the Sponsor loaned the Company an aggregate of up to $950,250 to cover expenses related to the Company’s initial business combination pursuant to a promissory note (the “Second Note”). The Second Note is noninterest bearing and payable on the earliest of: (i) the consummation of the Company’s initial business combination unless converted into working capital warrants at the option of the Sponsor, at a price of $0.75 per warrant, as described in the registration statement that the Company filed in connection with the initial public offering of its securities, (ii) August 17, 2024, and (iii) the liquidation of the Company. Such working capital warrants would be identical to the private placement warrants issued to the Sponsor in a private placement in connection with the Company’s initial public offering. As of June 30, 2024 and December 31, 2023, the fair value of the Second Note was $950,250 (see Note 4). Based upon the analysis above, management has determined that the Company does not have sufficient liquidity to meet its anticipated obligations for at least twelve months after the financial statements are issued, as such, the events and circumstances raise substantial doubt about the Company’s ability to continue as a going concern. In connection with our assessment of going concern considerations in accordance with the ASC 205-40,

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	NOTE 2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 8 of Regulation S-X. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K “Form 10-K”) Form 10-K. Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of June 30, 2024 and December 31, 2023. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of June 30, 2024 and December 31, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, “Fair Value Measurements,” equal or approximate the carrying amounts represented in the condensed balance sheets. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The 20,700,000 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 18,720,000 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. as non-current Working Capital Loans-Related Party The Company has elected the fair value option to account for its Working Capital Loans with its Sponsor as defined and more fully described in Note 4. As a result of applying the fair value option, the Company records the loans fair value with a gain or loss recognized at issuance, and subsequent changes in fair value are recorded as change in the fair value of Working Capital Loans reported in the unaudited condensed statements of operations. The fair value is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumption about the assumptions a market participant would use in pricing the asset or liability. Offering Costs Associated with Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Class A ordinary shares were charged against the carrying value of Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 4,542,733 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets as of June 30, 2024 and December 31, 2023. Effective with the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount, which resulted in charges against additional paid-in Net Income per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average shares of ordinary shares outstanding for the respective period. The calculation of diluted net income does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering (including the consummation of the over-allotment) and the Private Placement Warrants to purchase an aggregate of 39,420,000 Class A ordinary shares, or the effects of the 1,467,000 shares underlying the warrants that would be issuable upon conversion of the Working Capital Loans (as defined in Note 4) in the calculation of diluted income per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. The Company has considered the effect of Class B ordinary shares that were excluded from the weighted average number of basic shares outstanding as they were contingent on the exercise of over-allotment option by the underwriters. Since the contingency was satisfied, the Company has included these shares in the weighted average number as of the beginning of the period to determine the dilutive impact of these shares. Remeasurement of the redeemable Class A ordinary shares is excluded from net income per share as the redemption value approximates fair value. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the For the Class A Class B Class A Class B Basic and Diluted net income per ordinary share: Numerator: Allocation of net income $ 633,763 $ 962,628 $ 6,672,292 $ 1,668,073 Denominator: Basic and Diluted weighted average ordinary shares outstanding 4,542,733 6,900,000 27,600,000 6,900,000 Basic and Diluted net income per ordinary share $ 0.14 $ 0.14 $ 0.24 $ 0.24 For the June 30, 2024 For the June 30, 2023 Class A Class B Class A Class B Basic and Diluted net income per ordinary share: Numerator: Allocation of net income $ 1,490,267 $ 2,263,580 $ 5,442,123 $ 1,360,531 Denominator: Basic and Diluted weighted average ordinary shares outstanding 4,542,733 6,900,000 27,600,000 6,900,000 Basic and Diluted net income per ordinary share $ 0.33 $ 0.33 $ 0.20 $ 0.20 Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed de minimis as of June 30, 2024 and December 31, 2023 and a full valuation allowance was recorded against such deferred tax assets. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2024 and December 31, 2023. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent Accounting Pronouncements In June 2022, the FASB issued ASU 2022-03, Contractual In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which expands disclosures in an entity’s income tax rate reconciliation table and disclosures regarding cash taxes paid both in the U.S. and foreign jurisdictions. The update will be effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the impact that this ASU will have on the presentation of its consolidated financial statements. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

Initial Public Offering

Initial Public Offering	6 Months Ended
	Jun. 30, 2024
Stockholders' Equity Note [Abstract]
Initial Public Offering	NOTE 3. INITIAL PUBLIC OFFERING On August 17, 2021, the Company consummated its Initial Public Offering of 27,600,000 Units, which includes the exercise in full of the underwriters’ option to purchase 3,600,000 Units, at $10.00 per Unit, generating gross proceeds of $276.0 million, and incurring offering costs of approximately $15.7 million, of which approximately $9.7 million and approximately $889,000 was for deferred underwriting commissions and offering costs allocated to derivate warrant liabilities, respectively. Each Unit consists of one Class A ordinary share (such shares included in the Units being offered, the “Public Shares”), and three-fourths of one redeemable warrant (each, a “Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7).

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2024
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 4. RELATED PARTY TRANSACTIONS Founder Shares On March 31, 2021, the Sponsor paid $25,000 to cover certain expenses on behalf of the Company in exchange for issuance of 7,475,000 of the Company’s Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”). Shares and the associated amounts have been retroactively restated to reflect: (i) the surrender of 1,006,250 Class B ordinary shares to the Company for no consideration on August 6, 2021; and (ii) the share issue of 431,250 Class B ordinary shares on August 12, 2021; resulting in an aggregate of 6,900,000 Class B ordinary shares outstanding. The initial shareholders agreed to forfeit up to 900,000 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. The underwriters fully exercised the over-allotment on August 17, 2021; thus, these 900,000 Founder Shares were no longer subject to forfeiture. The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, 30-trading Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Initial Private Placement of 11,360,000 Private Placement Warrants at a price of $0.75 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $8.5 million. Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share, subject to adjustment. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable The Sponsor agreed, subject to limited exceptions, not to transfer, assign or sell the Private Placement Warrants until 30 days after the completion of the initial Business Combination. On each of August 4, 2022 and February 15, 2023, the Company consummated the Additional Private Placements of 3,680,000 Additional Private Placement Warrants at a price of $0.75 per Additional Private Placement Warrant, generating total proceeds in aggregate of $5,520,000. The Additional Private Placement Warrants were purchased by the Sponsor and are substantially similar to the Private Placement Warrants issued to the Sponsor at the time of the Company’s Initial Public Offering. The Additional Private Placement Warrants have been issued pursuant to, and are governed by, the Warrant Agreement that the Company entered into at the time of the Initial Public Offering. Upon closing of the Additional Private Placements, the proceeds received by the Company in connection with the issuance of the Additional Private Placement Warrants were deposited in the Trust Account. Related Party Loans On March 24, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans could be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $2,000,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $0.75 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Company has drawn $150,000 under the Note, which was converted into a Working Capital Loan on August 17, 2021. As of June 30, 2024 and December 31, 2023, the fair value of this Working Capital Loan was $150,000 in the accompanying condensed balance sheets. On August 29, 2023, the Sponsor loaned the Company an aggregate of up to $950,250 to cover expenses related to the Company’s initial business combination pursuant to a promissory note (the “Second Note”). The Second Note is noninterest bearing and payable on the earliest of: (i) the consummation of the Company’s initial business combination unless converted into working capital warrants at the option of the Sponsor, at a price of $0.75 per warrant, as described in the registration statement that the Company filed in connection with the initial public offering of its securities, (ii) August 17, 2024, and (iii) the liquidation of the Company. Such working capital warrants would be identical to the private placement warrants issued to the Sponsor in a private placement in connection with the Company’s initial public offering. As of June 30, 2024 and December 31, 2023, the fair value of the Second Note was $950,250. Service and Administrative Fees On August 12, 2021, the Company entered into an agreement with DEHC LLC, an affiliate of the Company’s Chief Financial Officer, pursuant to which the Company agreed to pay for service and administrative fees of $20,000 per month for 18 months (or until February 12, 2023). On August 29, 2023, the agreement was amended to extend the services for the period from August 17, 2023 to August 17, 2024 with the same monthly payment. For the three months ended June 30, 2024 and 2023, the Company incurred $60,000 and $0, respectively, for such expenses, included as general and administrative expenses-related party on the statements of operations contained herein. For the six months ended June 30, 2024 and 2023, the Company incurred $120,000 and $20,000, respectively, for such expenses, included as general and administrative expenses-related party on the statements of operations contained herein. As of June 30, 2024 and December 31, 2023, the Company had no outstanding balance for services in connection with such agreement. The Sponsor, executive officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket Non-Redemption On August 11, 2023 and August 14, 2023, the Company entered into Non-Redemption Non-Redemption non-redeeming paid-in The fair value of the Sponsor shares was based on the following significant inputs: August 15, Risk-free interest rate 5.36 % Remaining life of SPAC 0.62 Underlying stock price $ 10.00 Probability of transaction 10 %

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 5. COMMITMENTS AND CONTINGENCIES Registration Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares are entitled to registration rights pursuant to a registration rights agreement signed upon the consummation of the Initial Public Offering. These holders are entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day The underwriters were entitled to an underwriting discount of $0.20 per unit, or approximately $5.5 million in the aggregate, paid upon the closing of the Initial Public Offering. $0.35 per unit, or approximately $9.7 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Contingent Fee Arrangement On August 3, 2023, the Company entered into an arrangement with J.V.B Financial Group, acting through its Cohen & Company Capital Markets division (“CCM”) to obtain capital market advisory services and to act as the Company’s placement agent in connection with raising capital with a specific target in its search for a Business Combination with an unaffiliated third party (“Target”). CCM would be entitled to an advisor fee of $2.0 million and a transaction fee of an amount equal to 5% of the sum of the gross proceeds raised from investors and received by the Company and Target plus proceeds released from the Trust Account without restriction with respect to any of the Class A ordinary shares that did not redeem such shares in connection with the Extension or the Business Combination (“Arrangement”). The Company may pay CCM a discretionary fee of $1.0 million if the Company determines in its sole discretion that the performance of CCM warrants such additional fee. Per the Arrangement, the fees for these services are contingent upon the closing of a Business Combination and therefore not included as liabilities on the accompanying condensed balance sheets. Under the Arrangement, the Company will also reimburse CCM for reasonable expenses. As of June 30, 2024 and December 31, 2023, no expenses have been claimed.

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject to Possible Redemption	6 Months Ended
	Jun. 30, 2024
Temporary Equity Disclosure [Abstract]
Class A Ordinary Shares Subject to Possible Redemption	NOTE 6. CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 100,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. On August 15, 2023, holders of 23,057,267 Class A ordinary shares exercised their right to redeem their shares for cash at a redemption price of approximately $10.67 per share, for an aggregate redemption amount of approximately $246.0 million. As of June 30, 2024 and December 31, 2023, there were 4,542,733 Class A ordinary shares outstanding, all of which were subject to possible redemption. The Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets are reconciled in the following table: Class A ordinary shares subject to possible redemption, December 31, 2022 $ 282,942,286 Extension payment made by the Sponsor 2,760,000 Redemption of Class A ordinary shares subject to possible redemption (245,963,349 ) Remeasurement of redemption value of Class A ordinary shares subject to possible redemption 9,377,784 Class A ordinary shares subject to possible redemption, December 31, 2023 $ 49,116,721 Remeasurement of Class A ordinary shares subject to possible redemption amount 1,519,481 Class A ordinary shares subject to possible redemption, June 30, 2024 (unaudited) $ 50,636,202

Shareholder's Deficit

Shareholder's Deficit	6 Months Ended
	Jun. 30, 2024
Stockholders' Equity Note [Abstract]
Shareholder's Deficit	NOTE 7. SHAREHOLDERS’ DEFICIT Preference Shares- Class A Ordinary Shares- Class B Ordinary Shares- Shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders; provided that, prior to the completion of the initial Business Combination, holders of the Class B ordinary shares will have the right to elect all of the Company’s directors and remove members of the Company’s board of directors for any reason. Prior to the completion of the initial Business Combination, only holders of the Class B ordinary shares will have the right to vote on the Company’s appointment of directors. Holders of the Public Shares will not be entitled to vote on the Company’s appointment of directors during such time. In addition, prior to the completion of the initial Business Combination, holders of a majority of the outstanding Class B ordinary shares may remove a member of the Company’s board of directors for any reason. These provisions of the Memorandum and Articles may only be amended by a resolution passed by at least two-thirds The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination, or earlier at the option of the holders, on a one-for-one sub-divisions, In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Proposed Offering and related to the closing of the initial Business Combination, including pursuant to a specified future issuance, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the then-outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance, including a specified future issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted

Derivative Warrant Liabilities

Derivative Warrant Liabilities	6 Months Ended
	Jun. 30, 2024
Derivative Warrant Liabilities Disclosure [Abstract]
Derivative Warrant Liabilities	NOTE 8. DERIVATIVE WARRANT LIABILITIES As of June 30, 2024 and December 31, 2023, the Company had 20,700,000 Public Warrants and 18,720,000 Private Placement Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination; provided that the Company has an effective registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their Public Warrants on a cashless basis under the circumstances specified in the warrant agreement). The Company agreed that as soon as practicable, but in no event later than 20 business days, after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following the initial Business Combination to have declared effective, a post-effective amendment to the registration statement of which this Report forms a part or a new registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed; provided, that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, but it will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The warrants will have an exercise price of $11.50 per share, subject to adjustments. In addition, if (x) the Company issues additional shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (as adjusted for share sub-divisions, by the Company’s board of directors, and in the case of any such issuance to the Sponsor, initial shareholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the Initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of each warrant will be adjusted (to the nearest cent) such that the effective exercise price per full share will be equal to 115% of the higher of (i) the Market Value and (ii) the Newly Issued Price, and the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of (i) the Market Value and (ii) the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants, except that (1) the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (2) the Private Placement Warrants are non-redeemable, Redemption of warrants for cash when the price per Class A ordinary share equals or exceeds $18.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except for the Private Placement Warrants). • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; and • if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within the 30-trading If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 9. FAIR VALUE MEASUREMENTS The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2024 and December 31, 2023 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value: June 30, 2024 Description Quoted Significant Significant Assets: Investments held in Trust Account - Money Market Funds (1) $ 50,735,549 $ —  $ —  Liabilities: Derivative Warrant Liabilities $ 621,000 $ —  $ —  Derivative Warrant Liabilities - Private Warrants $ —  $ $ 561,600 Working Capital Loan – Related Party $ —  $ —  $ 1,100,250 December 31, 2023 Description Quoted Significant Significant Assets: Investments held in Trust Account - Money Market Funds (1) $ 49,216,069 $ —  $ —  Liabilities: Derivative Warrant Liabilities $ 2,070,000 $ —  $ —  Derivative Warrant Liabilities - Private Warrants $ —  $ —  $ 1,872,000 Working Capital Loan – Related Party $ —  $ —  $ 1,100,250 (1) Excludes $653 and $652 of cash balance held within the Trust Account as of June 30, 2024 and December 31, 2023, respectively Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. There were no transfers to/from Levels 1, 2, and 3 during the three and six months ended June 30, 2024 or 2023. Level 1 assets include investments in U.S. government securities. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. The Public Warrants were valued using an observable market quote in an active market as of June 30, 2024 and December 31, 2023. As of June 30, 2024, the estimated fair value of the Private Placement Warrants and Working Capital Loans were based on the observable fair value of the Public Warrants as of June 30, 2024 with consideration of certain terms of the Private Placement Warrants and Working Capital Loans. non-operating non-operating The change in the valuation technique used to determine the fair value of the Private Placement Warrants and Working Capital loans was due to the limited market activity. The Company determined the fair value of each Private Warrant was consistent with that of a Public Warrant. For the fair value of the Working Capital Loans, the Company considered the expected settlement of the Working Capital Loans by a market participant and also relied on the fair value of the Public Warrants, as the warrants that would be converted from the Working Capital Loan would be identical to the Private Placement Warrants. As of December 31, 2023 the estimated fair value of the Private Placement Warrants and Working Capital Loan was determined using Level 3 inputs. Inherent in a Black-Scholes option pricing model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate, and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer companies’ ordinary shares that match the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield The following table provides quantitative information regarding Level 3 fair value measurements input for Private Placement Warrants, and Working Capital Loan at their measurement dates: December 31, Exercise price $ 11.50 Stock price $ 10.69 Volatility 5.2 % Term (years) 5.58 Risk-free rate 3.78 % Dividend yield 0.00 % (Note: To determine the fair value of the Working Capital Loan, the Company relied on the inputs of the Private Placement Warrants, as the warrants that would be converted from the Working Capital Loan would be identical to the Private Placement Warrants.) The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the period from December 31, 2022 through June 30, 2024, is summarized as follows: Derivative warrant liabilities at December 31, 2022 $ 2,556,800 Issuance of Additional Private Placement Warrants 552,000 Change in fair value of derivative warrant liabilities (1,236,800 ) Derivative warrant liabilities at December 31, 2023 $ 1,872,000 Change in fair value of derivative warrant liabilities (1,310,400 ) Derivative warrant liabilities at June 30, 2024 (unaudited) $ 561,600 The change in the fair value of the Working Capital Loan-related party, measured using Level 3 inputs, for the period from December 31, 2022 through June 30, 2024, is summarized as follows: Working Capital Loan - related party as of December 31, 2022 $ 150,000 Additional Working Capital Loan - related party 950,250 Change in fair value of Working Capital Loan – related party —  Working Capital Loan - related party as of December 31, 2023 $ 1,100,250 Change in fair value of Working Capital Loan - related party —  Working Capital Loan - related party as of June 30, 2024 (unaudited) $ 1,100,250

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	NOTE 10. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred up to the date unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment to or disclosure in the unaudited condensed financial statements, except as noted below. On August 1, 2024, we issued a press release announcing we will not complete a Business Combination and will redeem all of our outstanding Class A ordinary shares. The redemption is expected to occur on August 19, 2024.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Basis of presentation	Basis of Presentation The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 8 of Regulation S-X. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K “Form 10-K”) Form 10-K.
Use of estimates	Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and cash equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of June 30, 2024 and December 31, 2023.
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Concentration of credit risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of June 30, 2024 and December 31, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.
Fair value of financial instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, “Fair Value Measurements,” equal or approximate the carrying amounts represented in the condensed balance sheets.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments	Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The 20,700,000 warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the 18,720,000 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. as non-current
Working Capital Loan-Related Party	Working Capital Loans-Related Party The Company has elected the fair value option to account for its Working Capital Loans with its Sponsor as defined and more fully described in Note 4. As a result of applying the fair value option, the Company records the loans fair value with a gain or loss recognized at issuance, and subsequent changes in fair value are recorded as change in the fair value of Working Capital Loans reported in the unaudited condensed statements of operations. The fair value is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumption about the assumptions a market participant would use in pricing the asset or liability.
Offering costs associated with Initial Public Offering	Offering Costs Associated with Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Class A ordinary shares were charged against the carrying value of Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 4,542,733 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets as of June 30, 2024 and December 31, 2023. Effective with the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount, which resulted in charges against additional paid-in
Net Income per Ordinary Share	Net Income per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average shares of ordinary shares outstanding for the respective period. The calculation of diluted net income does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering (including the consummation of the over-allotment) and the Private Placement Warrants to purchase an aggregate of 39,420,000 Class A ordinary shares, or the effects of the 1,467,000 shares underlying the warrants that would be issuable upon conversion of the Working Capital Loans (as defined in Note 4) in the calculation of diluted income per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. The Company has considered the effect of Class B ordinary shares that were excluded from the weighted average number of basic shares outstanding as they were contingent on the exercise of over-allotment option by the underwriters. Since the contingency was satisfied, the Company has included these shares in the weighted average number as of the beginning of the period to determine the dilutive impact of these shares. Remeasurement of the redeemable Class A ordinary shares is excluded from net income per share as the redemption value approximates fair value. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the For the Class A Class B Class A Class B Basic and Diluted net income per ordinary share: Numerator: Allocation of net income $ 633,763 $ 962,628 $ 6,672,292 $ 1,668,073 Denominator: Basic and Diluted weighted average ordinary shares outstanding 4,542,733 6,900,000 27,600,000 6,900,000 Basic and Diluted net income per ordinary share $ 0.14 $ 0.14 $ 0.24 $ 0.24 For the June 30, 2024 For the June 30, 2023 Class A Class B Class A Class B Basic and Diluted net income per ordinary share: Numerator: Allocation of net income $ 1,490,267 $ 2,263,580 $ 5,442,123 $ 1,360,531 Denominator: Basic and Diluted weighted average ordinary shares outstanding 4,542,733 6,900,000 27,600,000 6,900,000 Basic and Diluted net income per ordinary share $ 0.33 $ 0.33 $ 0.20 $ 0.20
Income taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed de minimis as of June 30, 2024 and December 31, 2023 and a full valuation allowance was recorded against such deferred tax assets. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2024 and December 31, 2023. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent accounting pronouncements	Recent Accounting Pronouncements In June 2022, the FASB issued ASU 2022-03, Contractual In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which expands disclosures in an entity’s income tax rate reconciliation table and disclosures regarding cash taxes paid both in the U.S. and foreign jurisdictions. The update will be effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the impact that this ASU will have on the presentation of its consolidated financial statements. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.
New accounting pronouncements not yet adopted	In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which expands disclosures in an entity’s income tax rate reconciliation table and disclosures regarding cash taxes paid both in the U.S. and foreign jurisdictions. The update will be effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the impact that this ASU will have on the presentation of its consolidated financial statements.

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Summary of basic and diluted net income (loss) per common share	The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the For the Class A Class B Class A Class B Basic and Diluted net income per ordinary share: Numerator: Allocation of net income $ 633,763 $ 962,628 $ 6,672,292 $ 1,668,073 Denominator: Basic and Diluted weighted average ordinary shares outstanding 4,542,733 6,900,000 27,600,000 6,900,000 Basic and Diluted net income per ordinary share $ 0.14 $ 0.14 $ 0.24 $ 0.24 For the June 30, 2024 For the June 30, 2023 Class A Class B Class A Class B Basic and Diluted net income per ordinary share: Numerator: Allocation of net income $ 1,490,267 $ 2,263,580 $ 5,442,123 $ 1,360,531 Denominator: Basic and Diluted weighted average ordinary shares outstanding 4,542,733 6,900,000 27,600,000 6,900,000 Basic and Diluted net income per ordinary share $ 0.33 $ 0.33 $ 0.20 $ 0.20

Related Party Transactions (Tab

Related Party Transactions (Tables)	6 Months Ended
	Jun. 30, 2024
Related Party Transactions [Abstract]
Summary of Significant Inputs Used in the Valuation of Fair Value of the Sponsor Shares	The fair value of the Sponsor shares was based on the following significant inputs: August 15, Risk-free interest rate 5.36 % Remaining life of SPAC 0.62 Underlying stock price $ 10.00 Probability of transaction 10 %

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject to Possible Redemption (Tables)	6 Months Ended
	Jun. 30, 2024
Temporary Equity Disclosure [Abstract]
Summary of Class A Common Stock Subject to Possible Redemption	The Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets are reconciled in the following table: Class A ordinary shares subject to possible redemption, December 31, 2022 $ 282,942,286 Extension payment made by the Sponsor 2,760,000 Redemption of Class A ordinary shares subject to possible redemption (245,963,349 ) Remeasurement of redemption value of Class A ordinary shares subject to possible redemption 9,377,784 Class A ordinary shares subject to possible redemption, December 31, 2023 $ 49,116,721 Remeasurement of Class A ordinary shares subject to possible redemption amount 1,519,481 Class A ordinary shares subject to possible redemption, June 30, 2024 (unaudited) $ 50,636,202

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Summary of assets and liabilities that are measured at fair value on a recurring basis	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2024 and December 31, 2023 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value: June 30, 2024 Description Quoted Significant Significant Assets: Investments held in Trust Account - Money Market Funds (1) $ 50,735,549 $ —  $ —  Liabilities: Derivative Warrant Liabilities $ 621,000 $ —  $ —  Derivative Warrant Liabilities - Private Warrants $ —  $ $ 561,600 Working Capital Loan – Related Party $ —  $ —  $ 1,100,250 December 31, 2023 Description Quoted Significant Significant Assets: Investments held in Trust Account - Money Market Funds (1) $ 49,216,069 $ —  $ —  Liabilities: Derivative Warrant Liabilities $ 2,070,000 $ —  $ —  Derivative Warrant Liabilities - Private Warrants $ —  $ —  $ 1,872,000 Working Capital Loan – Related Party $ —  $ —  $ 1,100,250 (1) Excludes $653 and $652 of cash balance held within the Trust Account as of June 30, 2024 and December 31, 2023, respectively
Summary of quantitative information regarding Level 3 fair value measurements input	The following table provides quantitative information regarding Level 3 fair value measurements input for Private Placement Warrants, and Working Capital Loan at their measurement dates: December 31, Exercise price $ 11.50 Stock price $ 10.69 Volatility 5.2 % Term (years) 5.58 Risk-free rate 3.78 % Dividend yield 0.00 %
Summary of fair value of the derivative liabilities, measured using Level 3 inputs	The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the period from December 31, 2022 through June 30, 2024, is summarized as follows: Derivative warrant liabilities at December 31, 2022 $ 2,556,800 Issuance of Additional Private Placement Warrants 552,000 Change in fair value of derivative warrant liabilities (1,236,800 ) Derivative warrant liabilities at December 31, 2023 $ 1,872,000 Change in fair value of derivative warrant liabilities (1,310,400 ) Derivative warrant liabilities at June 30, 2024 (unaudited) $ 561,600
Summary of change in the fair value of the Working Capital Loan – related party, measured using Level 3 inputs	The change in the fair value of the Working Capital Loan-related party, measured using Level 3 inputs, for the period from December 31, 2022 through June 30, 2024, is summarized as follows: Working Capital Loan - related party as of December 31, 2022 $ 150,000 Additional Working Capital Loan - related party 950,250 Change in fair value of Working Capital Loan – related party —  Working Capital Loan - related party as of December 31, 2023 $ 1,100,250 Change in fair value of Working Capital Loan - related party —  Working Capital Loan - related party as of June 30, 2024 (unaudited) $ 1,100,250

Description of Organization a_2

Description of Organization and Business Operations - Additional Information (Detail) - USD ($)

6 Months Ended

Aug. 01, 2024

Aug. 15, 2023

Aug. 14, 2023

Aug. 11, 2023

Feb. 15, 2023

Aug. 17, 2022

Aug. 04, 2022

Aug. 17, 2021

Jun. 30, 2024

Jun. 30, 2023

Dec. 31, 2023

Aug. 29, 2023

Mar. 31, 2021

Mar. 24, 2021

Entity incorporation, date of incorporation

Mar. 19, 2021

Deferred underwriting commissions

$ 9,660,000

$ 9,660,000

Proceeds From Issuance Of Warrants

0

$ 2,760,000

Payment to acquire restricted investments

$ 0

$ 2,760,000

Restricted investments term

185 days

Percentage of redeeming shares of public shares without the company's prior written consent

15%

Percentage of public shares to be redeemed on non completion of business combination

100%

Redemption of public shares after closing of IPO date

Aug. 17, 2023

Cash

$ 879,486

1,222,918

Working capital (deficit)

$ 2,500,000

Period within which initial business combination shall be consummated from the closing of initial public offering

12 months

Anticipated period within which initial business combination shall not be able to consummate

12 months

Extended each by additional period within which initial business combination shall be consummate with the option of sponsor

6 months

Extended total additional period within which initial business combination shall be consummate with the option of sponsor

12 months

Per share value of residual assets remaining available for distribution

$ 10

Working Capital Loan - related party

$ 1,100,250

1,100,250

Second Promissory Note [Member]

Debt fair value

$ 950,250

950,250

Post Business Combination Target Company [Member]

Business acquisition, percentage of voting interests acquired

50%

Working Capital Loan [Member]

Debt instrument amount

$ 2,000,000

Debt instrument, convertible, conversion price

$ 0.75

Subsequent Event [Member]

Description of subsequent event

On August 1, 2024, the Company issued a press release announcing that it will be unable to complete a business combination and intends to dissolve and liquidate in accordance with the provisions of its Memorandum and Articles.

Minimum [Member]

Percentage of fair market value of target business to asset held in trust account

80%

Per share amount to be maintained in the trust account

$ 10

Maximum [Member]

Per share amount to be maintained in the trust account

$ 10

Private Placement Warrants [Member]

Stock issued during period shares

18,720,000

Sponsor [Member]

Debt instrument, face amount

$ 300,000

Sponsor [Member] | Second Promissory Note [Member]

Debt instrument, face amount

$ 950,250

Sponsor [Member] | Working Capital Loan [Member]

Debt instrument amount

$ 150,000

Working Capital Loan - related party

$ 150,000

$ 150,000

Sponsor [Member] | Working Capital Loan [Member] | Second Promissory Note [Member]

Debt instrument, convertible, conversion price

$ 0.75

Sponsor [Member] | Extend Period of Time for Business Combination [Member]

Deposit amount per each unit

$ 0.1

Sponsor [Member] | Founder Shares [Member]

Proceeds from Issuance of Common Stock

$ 25,000

Sponsor [Member] | Private Placement Warrants [Member]

Class of warrant or right, issued during the period

3,680,000

3,680,000

11,360,000

Class of warrant or right, issue price

$ 0.75

$ 0.75

$ 0.75

Proceeds From Issuance Of Warrants

$ 5,520,000

$ 5,520,000

$ 8,500,000

Class Of Warrants Or Rights Issued During The Period

3,680,000

3,680,000

Sponsor [Member] | Private Placement Warrants [Member] | Extend Period of Time for Business Combination [Member]

Class of warrant or right, issued during the period

3,680,000

Class of warrant or right, issue price

$ 0.75

Proceeds From Issuance Of Warrants

$ 2,800,000

IPO [Member]

Payment to acquire restricted investments

$ 276,000,000

Share price

$ 10

Class A ordinary shares [Member]

Stock issued during period shares

3,600,000

Common Stock par value

$ 0.0001

$ 0.0001

Class A ordinary shares [Member] | Subsequent Event [Member]

Ordinary stock redemption date expected

Aug. 19, 2024

Class A ordinary shares [Member] | Common Stock [Member] | Non Redemption Agreements [Member]

Stock issued during period shares

2,600,000

2,600,000

Shares redemeed, Shares

23,057,267

Redemption price per share

$ 10.67

Shares redemeed, Value

$ 246,000,000

Class A ordinary shares [Member] | IPO [Member]

Stock issued during period shares

27,600,000

Shares issued price per share

$ 10

Proceeds from issuance of IPO

$ 276,000,000

Stock issuance costs

15,700,000

Deferred underwriting commissions

9,700,000

Offering costs allocated to derivative warrant liabilities

$ 889,000

Class B ordinary shares [Member]

Common Stock par value

$ 0.0001

$ 0.0001

Class B ordinary shares [Member] | Common Stock [Member] | Non Redemption Agreements [Member]

Share price

$ 0.97

Aggregate common shares held by sponsor

568,750

Aggregate common shares held by sponsor, Value

$ 600,000

Class B ordinary shares [Member] | Sponsor [Member]

Common Stock par value

$ 0.0001

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)		6 Months Ended
	Aug. 17, 2021	Jun. 30, 2024	Dec. 31, 2023
Class of Warrant or Right [Line Items]
FDIC insured amount		$ 250,000
Cash equivalents		0	$ 0
Unrecognized tax benefits		0	0
Accrued for interest and penalties		$ 0	$ 0
Term of restricted investments		185 days
Public Warrants [Member]
Class of Warrant or Right [Line Items]
Stock issued during period shares	20,700,000
Private Placement Warrants [Member]
Class of Warrant or Right [Line Items]
Stock issued during period shares	18,720,000
Class A ordinary shares [Member]
Class of Warrant or Right [Line Items]
Number of common stock into which the class of warrant or right may be converted		39,420,000
Temporary equity shares issued		4,542,733	4,542,733
Stock issued during period shares	3,600,000
Convertible Common Stock [Member]
Class of Warrant or Right [Line Items]
Number of common stock into which the class of warrant or right may be converted		1,467,000

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income (Loss) Per Common Share (Detail) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Numerator:
Allocation of net income	$ 1,596,391	$ 2,157,456	$ 8,340,365	$ (1,537,711)	$ 3,753,847	$ 6,802,654
Common Class A [Member]
Numerator:
Allocation of net income	$ 633,763		$ 6,672,292		$ 1,490,267	$ 5,442,123
Denominator:
Weighted Average Number of Shares Outstanding, Basic	4,542,733		27,600,000		4,542,733	27,600,000
Weighted Average Number of Shares Outstanding, Diluted	4,542,733		27,600,000		4,542,733	27,600,000
Basic net income per ordinary share	$ 0.14		$ 0.24		$ 0.33	$ 0.2
Diluted net income per ordinary share	$ 0.14		$ 0.24		$ 0.33	$ 0.2
Common Class B [Member]
Numerator:
Allocation of net income	$ 962,628		$ 1,668,073		$ 2,263,580	$ 1,360,531
Denominator:
Weighted Average Number of Shares Outstanding, Basic	6,900,000		6,900,000		6,900,000	6,900,000
Weighted Average Number of Shares Outstanding, Diluted	6,900,000		6,900,000		6,900,000	6,900,000
Basic net income per ordinary share	$ 0.14		$ 0.24		$ 0.33	$ 0.2
Diluted net income per ordinary share	$ 0.14		$ 0.24		$ 0.33	$ 0.2

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - USD ($)		6 Months Ended
	Aug. 17, 2021	Jun. 30, 2024	Dec. 31, 2023
Deferred underwriting commissions noncurrent		$ 9,660,000	$ 9,660,000
Stock conversion basis		one-for-one basis
Public Warrants [Member]
Stock issued during period shares	20,700,000
Common Class A [Member]
Stock issued during period shares	3,600,000
Stock conversion basis	Each Unit consists of one Class A ordinary share (such shares included in the Units being offered, the “Public Shares”), and three-fourths of one redeemable warrant (each, a “Public Warrant”).
Common Class A [Member] | Public Warrants [Member]
Class of warrant or right, Number of securities called by each warrant or right	1
Class of warrant or right, Exercise price of warrants or rights	$ 11.5
IPO [Member] | Common Class A [Member]
Stock issued during period shares	27,600,000
Shares issued price per share	$ 10
Proceeds from issuance initial public offering	$ 276,000,000
Stock issuance costs	15,700,000
Deferred underwriting commissions noncurrent	9,700,000
Offering costs allocated to derivate warrant liabilities	$ 889,000
Over-Allotment Option [Member] | Common Class A [Member]
Stock issued during period shares	3,600,000

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)											3 Months Ended		6 Months Ended		9 Months Ended
	Aug. 17, 2023	Aug. 15, 2023	Aug. 14, 2023	Aug. 11, 2023	Feb. 15, 2023	Aug. 04, 2022	Aug. 17, 2021	Aug. 12, 2021	Aug. 06, 2021	Mar. 31, 2021	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2021	Dec. 31, 2023	Aug. 29, 2023	Mar. 24, 2021
Related Party Transaction [Line Items]
Founder Shares, Lock in period													1 year
Proceeds from issuance of warrants													$ 0	$ 2,760,000
Bank Overdrafts											$ 150,000		150,000
Administrative expenses—related party											60,000	$ 0	120,000	20,000
Working Capital Loan - related party											1,100,250		1,100,250			$ 1,100,250
Second Promissory Note [Member]
Related Party Transaction [Line Items]
Debt fair value											950,250		950,250			950,250
Working Capital Loan [Member]
Related Party Transaction [Line Items]
Debt instrument, convertible, carrying amount of equity component											$ 2,000,000		$ 2,000,000
Debt instrument, convertible, conversion price											$ 0.75		$ 0.75
Administrative Service Fee [Member]
Related Party Transaction [Line Items]
Administrative expenses—related party											$ 60,000	$ 0	$ 120,000	$ 20,000
Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Stock issued during period shares							18,720,000
Sponsor [Member]
Related Party Transaction [Line Items]
Debt instrument, face amount																		$ 300,000
Notes payable current											150,000		150,000
Sponsor [Member] | Second Promissory Note [Member]
Related Party Transaction [Line Items]
Debt instrument, face amount																	$ 950,250
Sponsor [Member] | Working Capital Loan [Member]
Related Party Transaction [Line Items]
Debt instrument, convertible, carrying amount of equity component							$ 150,000
Working Capital Loan - related party											$ 150,000		$ 150,000			150,000
Sponsor [Member] | Working Capital Loan [Member] | Second Promissory Note [Member]
Related Party Transaction [Line Items]
Debt instrument, convertible, conversion price																	$ 0.75
Sponsor [Member] | Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Class of warrant or right, issued during the period					3,680,000	3,680,000	11,360,000
Class of warrant or right, issue price					$ 0.75	$ 0.75	$ 0.75
Proceeds from issuance of warrants					$ 5,520,000	$ 5,520,000	$ 8,500,000
Lock in period for transfer of warrants from the date Of completion of business combination	30 days
Sponsor [Member] | Share Price Equals Or Exceeds Twelve Per USD [Member]
Related Party Transaction [Line Items]
Share price											$ 12		$ 12
Share transfer restriction, threshold consecutive trading days															20 days
Share transfer restriction, threshold trading days															30 days
Number of days for a particular event to get over for determining trading period															150 days
Chief Executive Officer [Member] | Administrative Service Fee [Member]
Related Party Transaction [Line Items]
Related party transaction, amounts of transaction								$ 20,000
Related party transaction settlement period								18 months
Service And Administrative Fee [Member]
Related Party Transaction [Line Items]
Outstanding balance for services in connection with such agreement											$ 0		$ 0			$ 0
Class A ordinary shares [Member]
Related Party Transaction [Line Items]
Common stock, par or stated value per share											$ 0.0001		$ 0.0001			$ 0.0001
Common stock, shares outstanding											4,542,733		4,542,733			4,542,733
Common stock, shares issued											4,542,733		4,542,733			4,542,733
Stock issued during period shares							3,600,000
Class A ordinary shares [Member] | Non-Redemption Agreements [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Stock issued during period shares			2,600,000	2,600,000
Class A ordinary shares [Member] | Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Stock issued during period shares							3,600,000
Class A ordinary shares [Member] | Sponsor [Member] | Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Class of warrant or right, Number of securities called by each warrant or right	1
Class of warrant or right, Exercise price of warrants or rights	$ 11.5
Common Class B [Member]
Related Party Transaction [Line Items]
Common stock, par or stated value per share											$ 0.0001		$ 0.0001			$ 0.0001
Common stock, shares outstanding											6,900,000		6,900,000			6,900,000
Common stock, shares issued											6,900,000		6,900,000			6,900,000
Common Class B [Member] | Non-Redemption Agreements [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Share price		$ 0.97
Aggregate common shares held by sponsor		568,750
Aggregate common shares held by sponsor, Value		$ 600,000
Common Class B [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Stock issued during period for services, Value										$ 25,000
Stock issued during period for services, Shares										7,475,000
Common stock, par or stated value per share										$ 0.0001
Stock Repurchased During Period, Shares									1,006,250
Stock Repurchased During Period, Value									$ 0
Common stock, shares outstanding							900,000
Percentage of ownership held by initial shareholders											20%		20%
Common stock, shares issued								431,250
Common Class B [Member] | Sponsor [Member] | Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Common stock, shares outstanding									6,900,000
Common Stock, Other Shares, Outstanding											900,000		900,000

Related Party Transactions - Su

Related Party Transactions - Summary of Significant Inputs Used in the Valuation of Fair Value of the Sponsor Shares (Detail)	Aug. 15, 2023
Risk-free interest rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value significant unobservable input entities own equity	5.36
Remaining life of SPAC [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value significant unobservable input entities own equity	0.62
Underlying stock price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value significant unobservable input entities own equity	10
Probability of transaction [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value significant unobservable input entities own equity	10

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	6 Months Ended
	Jun. 30, 2024	Dec. 31, 2023	Aug. 03, 2023
Deferred underwriting discount per unit	$ 0.2
Deferred underwriting discount	$ 5,500,000
Deferred underwriting commission per unit	$ 0.35
Deferred underwriting commissions	$ 9,660,000	$ 9,660,000
Cohen & Company Capital Markets division [Member]
Advisor fee			$ 2,000,000
Transaction fee			5%
Discretionary fee			$ 1,000,000
Other Commitment	$ 0	$ 0
Over-Allotment Option [Member]
Overallotment option vesting period	45 days
Common stock shares subscribed but not yet issued	3,600,000

Class A Ordinary Shares Subje_3

Class A Ordinary Shares Subject to Possible Redemption - Additional Information (Detail) - Common Class A [Member] - USD ($)	Aug. 15, 2023	Jun. 30, 2024	Dec. 31, 2023
Temporary Equity [Line Items]
Temporary equity shares authorized		100,000,000
Temporary equity, par value		$ 0.0001
Temporary equity shares outstanding		4,542,733	4,542,733
Common Stock [Member] | Non Redemption Agreements [Member]
Temporary Equity [Line Items]
Shares redemeed, Shares	23,057,267
Redemption price per share	$ 10.67
Shares redemeed, Value	$ 246,000,000

Class A Ordinary Shares Subje_4

Class A Ordinary Shares Subject to Possible Redemption - Summary Of Class A Ordinary Shares Subject To Possible Redemption (Detail) - USD ($)	3 Months Ended				6 Months Ended	12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Dec. 31, 2023
Temporary Equity [Line Items]
Remeasurement of redemption value of Class A ordinary shares subject to possible redemption	$ 652,586	$ 866,895	$ 2,522,626	$ 5,492,154
Common Class A [Member]
Temporary Equity [Line Items]
Class A ordinary shares subject to possible redemption, Beginning balance		$ 49,116,721		$ 282,942,286	$ 49,116,721	$ 282,942,286
Extension payment made by the Sponsor						2,760,000
Redemption of Class A ordinary shares subject to possible redemption						(245,963,349)
Remeasurement of redemption value of Class A ordinary shares subject to possible redemption					1,519,481	9,377,784
Class A ordinary shares subject to possible redemption, Ending balance	$ 50,636,202				$ 50,636,202	$ 49,116,721

Shareholder's Deficit - Additio

Shareholder's Deficit - Additional Information (Detail) - $ / shares		6 Months Ended
	Aug. 17, 2021	Jun. 30, 2024	Dec. 31, 2023
Preference stock, Par or stated value per share		$ 0.0001	$ 0.0001
Preference stock, Shares authorized		1,000,000	1,000,000
Preference stock, Shares issued		0	0
Preference stock, Shares outstanding		0	0
Common stock, Voting rights		one vote
Common stock, Conversion basis		one-for-one basis
Common Class A [Member]
Common stock, par or stated value per share		$ 0.0001	$ 0.0001
Common stock, shares authorized		100,000,000	100,000,000
Common stock, shares issued		4,542,733	4,542,733
Common stock, shares outstanding		4,542,733	4,542,733
Common stock, Conversion basis	Each Unit consists of one Class A ordinary share (such shares included in the Units being offered, the “Public Shares”), and three-fourths of one redeemable warrant (each, a “Public Warrant”).
Common Class A [Member] | IPO [Member]
Percentage of common stock outstanding after conversion		20%
Common Class B [Member]
Common stock, par or stated value per share		$ 0.0001	$ 0.0001
Common stock, shares authorized		10,000,000	10,000,000
Common stock, shares issued		6,900,000	6,900,000
Common stock, shares outstanding		6,900,000	6,900,000

Derivative Warrant Liabilities

Derivative Warrant Liabilities - Additional Information (Detail) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023	Aug. 17, 2021
Number of days after closing of the initial business combination within which the securities shall be filed	20 days
Number of days following the initial business combination within which securities registration shall be declared effective	60 days
Percentage of gross proceeds from equity issuance to total equity proceeds	60%
Warrant [Member]
Exercise price of warrants	$ 11.5
Share Price Less Than Nine Point Twenty Per USD [Member]
Share price	$ 9.2
Share Price Less Than Nine Point Twenty Per USD [Member] | Warrant [Member]
Class of warrant or right, Exercise price adjustment percentage	115%
Share Price Equals Or Exceeds Eighteen Per USD [Member] | Warrant [Member]
Class of warrant or right, Exercise price adjustment percentage	180%
Class A ordinary shares [Member]
Number of consecutive trading days for determining the share price		30 days
Number of trading days for determining the share price		20 days
Number of consecutive trading days determining volume weighted average trading price of shares	20 days
Class A ordinary shares [Member] | Share Price Below Nine Point Twenty Per USD [Member]
Volume weighted average trading price of shares	$ 9.2
Share Price Equal or Exceeds Eighteen Rupees per dollar [Member]
Share price		$ 18
Share Price Equal or Exceeds Eighteen Rupees per dollar [Member] | Class A ordinary shares [Member]
Share price	18
Redemption Trigger Price [Member] | Class A ordinary shares [Member]
Share price	$ 18
Public Warrants [Member]
Class of warrants or rights outstanding	20,700,000
Warrants and rights outstanding, term		5 years
Class of warrants redemption price per unit		$ 0.01
Class of warrant or right, Number of days after which warrants or rights become exercisable	30 days
Minimum notice period to be given to the holders of warrants		30 days
Public Warrants [Member] | Class A ordinary shares [Member]
Exercise price of warrants			$ 11.5
Private Placement Warrants [Member]
Class of warrants or rights outstanding	18,720,000
Private Placement Warrants [Member] | Class A ordinary shares [Member]
Lock in period	30 days

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Change in fair value of derivative warrant liabilities	$ (1,182,600)	$ (6,701,400)	$ (2,759,400)	$ (3,474,200)
Change in fair value of Working Capital Loan—related party			0	0
Derivative Warrant Liabilities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Change in fair value of derivative warrant liabilities	$ 1,200,000	$ 6,700,000	$ 2,800,000	$ 3,500,000

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets and Liabilities at Fair Value on Recurring Basis (Detail) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Assets:
Investments held in Trust Account	$ 50,736,202	$ 49,216,721
Liabilities:
Working Capital Loan -current related party	$ 1,100,250	$ 1,100,250
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Derivative Liability, Noncurrent	Derivative Liability, Noncurrent
Level 1 [Member] | Fair Value, Recurring [Member] | US Treasury Securities [Member]
Assets:
Investments held in Trust Account	$ 50,735,549	$ 49,216,069
Level 1 [Member] | Public Warrants [Member] | Fair Value, Recurring [Member]
Liabilities:
Derivative warrant liabilities	621,000	2,070,000
Level 3 [Member] | Fair Value, Recurring [Member]
Liabilities:
Working Capital Loan -current related party	1,100,250	1,100,250
Level 3 [Member] | Public Warrants [Member] | Fair Value, Recurring [Member]
Liabilities:
Derivative warrant liabilities	0	0
Level 3 [Member] | Private Placement Warrants [Member] | Fair Value, Recurring [Member]
Liabilities:
Derivative warrant liabilities	$ 561,600	$ 1,872,000

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Assets and Liabilities at Fair Value on Recurring Basis (Parenthetical) (Detail) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Investments held in Trust Account	$ 50,736,202	$ 49,216,721
Cash [Member]
Investments held in Trust Account	$ 653	$ 652

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs (Detail) - Level 3 [Member]	Dec. 31, 2023 yr
Exercise price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Significant Unobservable Input Liabilities	11.5
Stock price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Significant Unobservable Input Liabilities	10.69
Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Significant Unobservable Input Liabilities	5.2
Term (years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Significant Unobservable Input Liabilities	5.58
Risk-free rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Significant Unobservable Input Liabilities	0.0378
Dividend yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Significant Unobservable Input Liabilities	0

Fair Value Measurements - Sum_4

Fair Value Measurements - Summary of change in the fair value of the derivative liabilities measured using Level 3 inputs (Detail) - Derivative Warrant Liabilities [Member] - Level 3 [Member] - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative warrant liabilities	$ 1,872,000	$ 2,556,800
Issuance of Public and Private Placement Warrants		552,000
Change in fair value of derivative warrant liabilities	(1,310,400)	(1,236,800)
Derivative warrant liabilities	$ 561,600	$ 1,872,000

Fair Value Measurements - Sum_5

Fair Value Measurements - Summary of change in the fair value of the Working Capital Loan and Related Party Measured Using Level 3 Inputs (Detail) - Working Capital Loan Related Party [Member] - Level 3 [Member] - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Working Capital Loan-related party	$ 1,100,250	$ 150,000
Additional Working Capital Loan-related party		950,250
Change in fair value of Working Capital Loan-related party	0	0
Working Capital Loan-related party	$ 1,100,250	$ 1,100,250